The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

Healthcare

Oxygen fuelled Linde’s stock; vaccine cold chain may be next. Watch if the dream run continues.

Oxygen fuelled Linde’s stock; vaccine cold chain may be next. Watch if the dream run continues.
Oxygen fuelled Linde’s stock; vaccine cold chain may be next. Watch if the dream run continues.
Linde Plant in West Bengal, India.

Synopsis

After rising more than 100% during the pandemic on the back of oxygen demand, Linde India’s shares could get another boost from the need for vaccine cold chains. But will this transform the company’s fundamentals in the long run?

Oxygen cylinders have saved more lives in the last six months than they ever did in the last many years. Thanks to Covid-19, which affects a patient’s respiratory system, oxygen cylinders were in high demand. While the virus broke the back of the economy of the biggest countries, investors were looking for pharma stocks and other allied industries which could benefit from the pandemic. A top draw was the oxygen-cylinder industry, in which Linde
Share This Article
  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • COMMENT

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise
The Economic Times